EDITORIAL
The increasing complexity of therapy -- and the danger that inadequate treatment can actually promote the development of drug-resistant viral strains -- argues in favor of this approach
PAUL A. VOLBERDING, M.D., EDITOR-IN-CHIEF
THERAPEUTIC ADVANCES
The incidence is down, the treatments are better, but the threat remains
JUDITH A. ABERG, M.D.
NEWSLINE
Delays in obtaining care pose risks to patients and community: Counseling is essential to ensure that newly diagnosed patients begin therapy promptly... Prophylaxis following sexual exposure to HIV: Treat within 72 hours, especially if risk of infection is high... CD4 count and viral load do predict progression in pediatric patients: Viral load above 100,000 copies/mL mandates a change in therapy... Reinfusion of autologous CD8 cells: Experimental technique seems to improve immunologic parameters...
PULL OUT AND SAVE
Schematic color diagrams that will help you explain to your patients what resistance is, how it arises, and what can be done to prevent it
MOLLY COOKE, M.D.
